Mining mountains of data for medical insights

June 24, 2014

Epidemiologists know that an important piece of evidence is often staring you in the face - but it's not always easy to see the forest for the trees.

Danish scientists recently teamed up with University of New Mexico researchers to test a powerful new method for predicting the progress of common diseases through time by teasing out previously undetected patterns from a very large data set - in this case, the health records of Denmark's entire population.

This approach maps out surprising correlations: a disease like gout - a form of arthritis - is strongly linked to cardiovascular disease, for example. In the future, this could enable physicians to make diagnoses sooner using simple tests in combination with known disease progression patterns.

The research is outlined in a study, "Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patients," published Tuesday in Nature Communications.

Pope Moseley, MD, chair of UNM's Department of Internal Medicine and Tudor Oprea, MD, PhD, professor of Internal Medicine and chief of UNM's Translational Informatics Division, collaborated with researchers from the Department of Systems Biology at the Technical University of Denmark, the Novo Nordisk Center for Protein Research at the University of Copenhagen and the Institute of Biological Psychiatry at Copenhagen University Hospital.

"This is a leap into a fairly large data base," Moseley says. "This method is able to recognize patterns in data that not only include diagnostic patterns, but includes the element of time and is able to build networks from that."

Denmark's electronic health registry covers that nation's entire population, with each person assigned a health number, Moseley says. Each medical diagnosis is coded in the registry using the International Classification of Diseases terminology - 101 million unique diagnoses in all.

"Every diagnosis on every Dane from every hospitalization and outpatient clinic visit is entered into the national health registry for the last 14 years," he says. "You're able to take these mass of data and look at it over time and begin to draw associations."

The team boiled down the massive trove of data to 1,171 so-called thoroughfares with central information on the course of diabetes, chronic obstructive pulmonary disease (COPD), cancer, arthritis and cardiovascular disease.

Lead author Anders Boeck Jensen says this data analysis method made it possible to view diseases in a larger context.

"Instead of looking at each disease in isolation, you can talk about a complex system with many different interacting factors," says Jensen, a post-doctoral fellow at the Center for Protein Research. "By looking at the order in which different diseases appear, you can start to draw patterns and see complex correlations outlining the direction for each individual person."

Oprea points out an additional advantage of the data-mining method. "The disease trajectories in this study follow causal relationships that were identified by a medically agnostic software," he says. "This illustrates the power of data mining as a means to uncover novel disease relationships and its ability to inform the health care sector about new avenues in patient management."

The data analysis showed, for example, that a diagnosis of anemia is typically followed months later by the discovery of colon cancer, Oprea says, "which suggests that cancer lesions were present and occult bleeding occurred, but remained undiagnosed."

Meanwhile, in addition to identifying gout as a step on the path toward cardiovascular disease, the team made surprising findings about COPD.

"In just looking at these codes that were based on age and gender and where the code was done, we were able to say that COPD is diagnosed late," Moseley says. "It's therefore under-diagnosed and probably because of that undertreated. All we have is this diagnostic code, but our analysis of the pattern said that."

That finding received unexpected support last February when another team published a paper on a large epidemiological study of 6,000 Danish COPD patients, each of whom was interviewed and subjected to extensive examination, laboratory review and testing.

"Their conclusion is COPD is diagnosed late, under-diagnosed and undertreated," Moseley says. "We were able to come to the same conclusions without ever having gone the other way. We essentially did the experiment with a computer out of a health registry."

The research could yield tangible health benefits as we move beyond one-size-fits-all medicine, says Prof. Lars Juhl Jensen of the Center for Protein Research.

"The perspective is that your genetic profile or the total network of associated proteins in your body, your proteome, can be mapped in a few years' time, enabling you to suddenly learn things about yourself which can be used to forecast the progress of diseases over an entire lifetime," he says.

Søren Brunak, a professor at the Technical University of Denmark and Center for Protein Research who served as senior author on the paper, adds that the sooner a health risk pattern is identified, "the better we can prevent and treat critical diseases."

Moseley describes the partnership with the Danes as "a really very nice marriage . . . it's a strong informatics and systems biology collaboration." Going forward, he hopes to access the data for even larger populations.

"The author Williams Gibson said something like, 'Everything we need to know about the future is here, now - you just have to be able to recognize the pattern,'" Moseley says. "Never was it more true."

University of New Mexico Health Sciences Center

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to